Mario Gabelli Regeneron Pharmaceuticals, Inc. Transaction History
Gamco Investors, Inc. Et Al
- $8.56 Billion
- Q2 2024
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 307 shares of REGN stock, worth $254,635. This represents 0.0% of its overall portfolio holdings.
Number of Shares
307
Previous 239
28.45%
Holding current value
$254,635
Previous $230,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,485Shares Held
85.7MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.46 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.01 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$6.87 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.02 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.85 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...